Skip to main content

Peer Review reports

From: A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit

Original Submission
6 Oct 2020 Submitted Original manuscript
16 Oct 2020 Author responded Author comments - Pierre-François Laterre
Resubmission - Version 2
16 Oct 2020 Submitted Manuscript version 2
Publishing
22 Oct 2020 Editorially accepted
25 Nov 2020 Article published 10.1186/s12890-020-01324-2

You can find further information about peer review here.

Back to article page